Business & Tech
LI Biotech's COVID-19 Vaccine Candidate Begins Production: Report
Codagenix's vaccine candidate has not yet begun its Phase 1 human clinical trials overseas, according to the report.
FARMINGDALE, NY — Codagenix Inc., a Farmingdale-based biotech company, recently saw its coronavirus vaccine candidate begin production by a global vaccine manufacturer, Newsday reported. The potential vaccine has not yet begun its Phase 1 human clinical trials in the United Kingdom, but those are expected to be underway by the end of the year, according to Newsday.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.